{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:05:59Z","timestamp":1789110359450,"version":"build-2803163510"},"reference-count":52,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Merck & Co., Inc.,"},{"name":"Merck Sharp & Dohme LLC,"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2726640","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:13:44Z","timestamp":1789107224000},"page":"2283-2294","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18\u201364 years in Switzerland using PCV21"],"prefix":"10.1080","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3738-6189","authenticated-orcid":false,"given":"Muloongo","family":"Simuzingili","sequence":"first","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4997-3121","authenticated-orcid":false,"given":"Zinan","family":"Yi","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7276-9706","authenticated-orcid":false,"given":"Andrea","family":"Favre-Bulle","sequence":"additional","affiliation":[{"name":"MSD Switzerland","place":["Lucerne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mutschler","sequence":"additional","affiliation":[{"name":"MSD Switzerland","place":["Lucerne, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5225-6874","authenticated-orcid":false,"given":"Eleana","family":"Tsoumani","sequence":"additional","affiliation":[{"name":"MSD Greece","place":["Alimos, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4519-2857","authenticated-orcid":false,"given":"Kwame","family":"Owusu-Edusei","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"European Centre for Disease Prevention and Control. Factsheet for health professionals about pneumococcal disease. [cited 2025 November 23]. https:\/\/www.ecdc.europa.eu\/en\/pneumococcal-disease\/facts."},{"key":"e_1_3_2_3_1","unstructured":"Bundesamt f\u00fcr Gesundheit. Pneumokokken-Erkrankungen. [cited 2026 April 9]. https:\/\/www.bag.admin.ch\/de\/pneumokokken-erkrankungen."},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu024"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2488189"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.2000892"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.128181"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00286"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-022-00097-y"},{"key":"e_1_3_2_10_1","unstructured":"Bundesamt f\u00fcr Gesundheit. Schweizerischer Impfplan 2026. [cited 2026 April 9]. https:\/\/www.bag.admin.ch\/dam\/de\/sd-web\/Oj0BSN-w-Ggs\/Schweizerischer%20Impfplan_2026_DE_Web_final.pdf."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.060"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9051078"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1147-x"},{"key":"e_1_3_2_14_1","unstructured":"Bundesamt f\u00fcr Gesundheit. Stellungnahme zur Verf\u00fcgbarkeit von verschieden-valenten Pneumokokken-Konjugatimpfstoffen pro Altersgruppe. [cited 2025 November 19]. https:\/\/www.bag.admin.ch\/dam\/de\/sd-web\/EbcWCBH-s3GG\/Stellungnahme%20EKIF_PCV%20Impfstoffe%20pro%20Altersgruppe_D_Stand%20070325_final_v2.pdf."},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.759602"},{"key":"e_1_3_2_16_1","unstructured":"Bundesamt f\u00fcr Gesundheit. Serotypes of Streptococcus pneumoniae causing invasive pneumococcal disease (IPD) Switzerland 2017\u20132023. 2025. (unpublished data)."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2228162"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127080"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00526-6"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03277-3"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2445429"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126985"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01067-1"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v51i23a03"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2026.2622857"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.06.007"},{"key":"e_1_3_2_27_1","unstructured":"Stoecker C. Economic Assessment of PCV21 in U.S. Adults (presentation to US Centers for Disease Control and Prevention\u2019s Advisory Committee on Immunization Practices). https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-06-26-28\/02-Pneumococcal-Stoecker-508.pdf."},{"key":"e_1_3_2_28_1","unstructured":"Swissmedic. Capvaxive Injektionsl\u00f6sung in Fertigspritze ((polysaccharida streptococci pneumoniae typus 3 6A 7F 8 9N 10A 11A 12F 15A 15B de-O-acetylatus 16F 17F 19A 20A 22F 23A 23B 24F 31 33F et 35B conjugata cum proteino corynebacteriae diphtheriae CRM 197). [cited 2025 November 23]. https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/humanarzneimittel\/authorisations\/new-medicines\/capvaxive-inlsg-fertigspritze.html."},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.04.016"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2046468"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003136"},{"key":"e_1_3_2_32_1","unstructured":"Leidner A. Summary of three economic models assessing pneumoccocal vaccines in US adults. CDC; 2021."},{"key":"e_1_3_2_33_1","unstructured":"Stoecker C. Economic assessment of PCV20 for children. 2023. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2023-06-21-23\/02-Pneumococcal-Stoecker-508.pdf."},{"key":"e_1_3_2_34_1","unstructured":"Federal Statistical Office. Permanent resident population by age sex and category of citizenship 2010\u20132023. [cited 2025 October 10]. https:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/population\/effectif-change\/age.assetdetail.32229042.html."},{"key":"e_1_3_2_35_1","unstructured":"Federal Statistical Office. Specific causes of death. [cited 2025 October 10]. https:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/health\/state-health\/mortality-causes-death\/specific.html."},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.048"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.02.017"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149540"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.04.008"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060273"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3529-4"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00325-2015"},{"key":"e_1_3_2_43_1","unstructured":"Bundesamt f\u00fcr Gesundheit. Capvaxive. [cited 2026 April 9]. https:\/\/sl.bag.admin.ch\/sl?search=Capvaxive&page=1&size=25."},{"key":"e_1_3_2_44_1","unstructured":"Bundesamt f\u00fcr Gesundheit. TARMED online browser. [cited 2025 November 4]. https:\/\/www.tarmed-browser.ch\/."},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.028"},{"key":"e_1_3_2_46_1","unstructured":"SwissDRG SA. Online Grouper. [cited 2025 November 4]. https:\/\/www.swissdrg.org\/fr\/grouper\/grouper\/online-grouper."},{"key":"e_1_3_2_47_1","unstructured":"Federal Statistical Office. Consumer price index global index in all index bases. [cited 2025 January 6]. https:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/prices\/consumer-price-index\/indexierung.html."},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197905"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.09.049"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.12.029"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v5i2.1649"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2025.106022"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.52225\/narrax.v3i3.230"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2726640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13696998.2026.2726640","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2726640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:13:49Z","timestamp":1789107229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2726640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2726640"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2726640","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}